Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-08-12 00:00:00 ET · period of report 2022-08-10 · accession 0000899243-22-028474 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-12 | 2022-08-10 | VRTX | Arbuckle Stuart A | EVP, COO | S - Sale+OE | $300.40 | -180 | 60.9K | -0.3% | -$54.1K |
| D | 2022-08-12 | 2022-08-10 | VRTX | Arbuckle Stuart A | EVP, COO | M - OptEx | $155.57 | +64 | 61.1K | +0.1% | +$9,956 |
| D | 2022-08-12 | 2022-08-10 | VRTX | Arbuckle Stuart A | EVP, COO | M - OptEx | $0.00 | -64 | 6,571 | -1.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-10 | S | D | 171 | $300.32 | 60,889 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-10 | S | D | 9 | $302.01 | 60,880 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-10 | M | A | 64 | $155.57 | 61,060 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-08-10 | M | D | 64 | $0.00 | 6,571 | D | $155.57 · — to 2028-02-05 | 64 Common Stock | (F2) Fully vested. |